0001140361-24-023012.txt : 20240429
0001140361-24-023012.hdr.sgml : 20240429
20240429163059
ACCESSION NUMBER: 0001140361-24-023012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240426
FILED AS OF DATE: 20240429
DATE AS OF CHANGE: 20240429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gurrola Sandra M
CENTRAL INDEX KEY: 0001618457
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11460
FILM NUMBER: 24891494
MAIL ADDRESS:
STREET 1: 2231 RUTHERFORD ROAD
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eterna Therapeutics Inc.
CENTRAL INDEX KEY: 0000748592
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 311103425
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1035 CAMBRIDGE STREET
STREET 2: SUITE 18A
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: (212) 582-1199
MAIL ADDRESS:
STREET 1: 10531 4S COMMONS DRIVE
STREET 2: SUITE 166-550
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
FORMER COMPANY:
FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc.
DATE OF NAME CHANGE: 20210325
FORMER COMPANY:
FORMER CONFORMED NAME: NTN BUZZTIME INC
DATE OF NAME CHANGE: 20051230
FORMER COMPANY:
FORMER CONFORMED NAME: NTN COMMUNICATIONS INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
FORM 4
X0508
4
2024-04-26
0000748592
Eterna Therapeutics Inc.
ERNA
0001618457
Gurrola Sandra M
C/O ETERNA THERAPEUTICS INC.
1035 CAMBRIDGE STREET, SUITE 18A
CAMBRIDGE
MA
02141
true
Sr. VP of Finance
false
Stock Option (Right to buy)
1.74
2024-04-26
4
A
0
80000
0
A
2034-04-26
Common Stock
80000
80000
D
The stock option shall vest in an initial installment of one-third on the one-year anniversary of the grant date, and the remaining shares shall vest in 24 substantially equal monthly installments thereafter.
/s/ Sandra Gurrola
2024-04-29